Astrazeneca

IMJUDO

View Prices
  1. Home
    2.  / 
  2. C Code
    3.  / IMJUDO – C9147

Manufacturer:

Astrazeneca

Name:

IMJUDO

HCPCS Code Descriptor:

Injection, tremelimumab-actl, 1 mg

Category:

C Code

HCPCS:

C9147

NDC(s):

00310-4505-25, 00310-4535-30,

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

IMJUDO is an Oncology drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The C Code: C9147 is aligned to the drug IMJUDO.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

4/1/23

HCPCS Effective Date:

7/1/23

HCPCS Short Description:

Inj, tremelimumab-actl, 1 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.azandmeapp.com/prescriptionsavings/

https://www.azandmeapp.com/prescriptionsavings/